Related Articles
17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy
Survivin, Ki‑67 and tumor grade as predictors of response to docetaxel‑based neoadjuvant chemotherapy in locally advanced breast cancer
Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer Corrigendum in /ol/5/4/1433